Cargando…
Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary
The goal of human-centered insulin pen design is to relieve the treatment burden of a chronic condition and help affected individuals to feel free of disease. The patient as well as their entire ecosystem should be considered. At Novo Nordisk A/S, we believe that embedding human-centered design at t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158249/ https://www.ncbi.nlm.nih.gov/pubmed/34852662 http://dx.doi.org/10.1177/19322968211058707 |
_version_ | 1784718796128256000 |
---|---|
author | Sparre, Thomas Hansen, Niels-Aage B. Wernersson, Anya Sonia Guarraia, Mark |
author_facet | Sparre, Thomas Hansen, Niels-Aage B. Wernersson, Anya Sonia Guarraia, Mark |
author_sort | Sparre, Thomas |
collection | PubMed |
description | The goal of human-centered insulin pen design is to relieve the treatment burden of a chronic condition and help affected individuals to feel free of disease. The patient as well as their entire ecosystem should be considered. At Novo Nordisk A/S, we believe that embedding human-centered design at the heart of our development processes is best achieved with multidisciplinary experts in-house to work alongside product development teams and, importantly, the end user. Novo Nordisk introduced the first commercially available insulin pen in 1985 and has continued to develop reusable/durable and prefilled insulin pens to meet different patient needs, through to the latest NovoPen 6 and NovoPen Echo Plus with SMART technology. Human-centered design is essential for delivering meaningful and practical solutions for individuals with diabetes. |
format | Online Article Text |
id | pubmed-9158249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-91582492022-06-02 Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary Sparre, Thomas Hansen, Niels-Aage B. Wernersson, Anya Sonia Guarraia, Mark J Diabetes Sci Technol Special Section: Insulin Pens The goal of human-centered insulin pen design is to relieve the treatment burden of a chronic condition and help affected individuals to feel free of disease. The patient as well as their entire ecosystem should be considered. At Novo Nordisk A/S, we believe that embedding human-centered design at the heart of our development processes is best achieved with multidisciplinary experts in-house to work alongside product development teams and, importantly, the end user. Novo Nordisk introduced the first commercially available insulin pen in 1985 and has continued to develop reusable/durable and prefilled insulin pens to meet different patient needs, through to the latest NovoPen 6 and NovoPen Echo Plus with SMART technology. Human-centered design is essential for delivering meaningful and practical solutions for individuals with diabetes. SAGE Publications 2022-12-01 /pmc/articles/PMC9158249/ /pubmed/34852662 http://dx.doi.org/10.1177/19322968211058707 Text en © 2021 Diabetes Technology Society https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Special Section: Insulin Pens Sparre, Thomas Hansen, Niels-Aage B. Wernersson, Anya Sonia Guarraia, Mark Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary |
title | Development of an Insulin Pen is a Patient-Centric Multidisciplinary
Undertaking: A Commentary |
title_full | Development of an Insulin Pen is a Patient-Centric Multidisciplinary
Undertaking: A Commentary |
title_fullStr | Development of an Insulin Pen is a Patient-Centric Multidisciplinary
Undertaking: A Commentary |
title_full_unstemmed | Development of an Insulin Pen is a Patient-Centric Multidisciplinary
Undertaking: A Commentary |
title_short | Development of an Insulin Pen is a Patient-Centric Multidisciplinary
Undertaking: A Commentary |
title_sort | development of an insulin pen is a patient-centric multidisciplinary
undertaking: a commentary |
topic | Special Section: Insulin Pens |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158249/ https://www.ncbi.nlm.nih.gov/pubmed/34852662 http://dx.doi.org/10.1177/19322968211058707 |
work_keys_str_mv | AT sparrethomas developmentofaninsulinpenisapatientcentricmultidisciplinaryundertakingacommentary AT hansennielsaageb developmentofaninsulinpenisapatientcentricmultidisciplinaryundertakingacommentary AT wernerssonanyasonia developmentofaninsulinpenisapatientcentricmultidisciplinaryundertakingacommentary AT guarraiamark developmentofaninsulinpenisapatientcentricmultidisciplinaryundertakingacommentary |